Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAAShell Companies
+$0.00 today
- Market cap
- $264.62M
- Beta
- 0.00
- P/E (TTM)
- 36.7
- EPS (TTM)
- $0.29
Volume 0.00M
Average 0.11M
DMAA Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Drugs Made In America Acquisition Corp. Ordinary SharesNASDAQ: DMAA
Retained Earnings · Q1 FY2026 · quarter ended Mar 2026
Retained earnings remains negative
Q1 FY2026 retained earnings was -$7.38M, compared with -$6.33M a year earlier.
Context
- Retained earnings amounted to 3.0% of total assets at the end of Q1 FY2026, up 0.3 pp from a year earlier.
What to watch
Whether retained earnings keeps falling in the next quarterly balance sheet after a -16.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
USD · from the balance sheet
- Latest · FY2025
- (7.27M) USD
- Year-over-year change
- -2603861.6%
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (7.27M) | -2603861.6% |
| FY2024 | 2024-12-31 | (279) | — |
Retained Earnings vs competitors
How DMAA compares with its peers on the latest reported figures
- DMAA's Mar 2026 retained earnings of -$7.38M is the 3rd highest of the 10 companies compared; the peer median is -$12.19M.
- Its year-over-year change of -16.7% is the 5th highest of 10, against a peer median of -172.1%.
- Retained earnings amounts to 3.0% of total assets for DMAA, versus a peer median of 3.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | -$61.84K | +99.4% | — | 0.0% | |
| Mar 2026 | -$1.13M | +83.5% | — | 0.5% | |
| Mar 2026 | -$7.38M | -16.7% | — | 3.0% | |
OYSEOyster Enterprises II Acquisition Corp | Mar 2026 | -$8.1M | -11062.9% | — | 3.1% |
| Mar 2026 | -$10.28M | -9.1% | — | 4.1% | |
TACOUBerto Acquisition Corp. Unit | Mar 2026 | -$12.19M | -1511.6% | — | 3.9% |
| Mar 2026 | -$12.19M | -1511.6% | — | 3.9% | |
TACHTitan Acquisition Corp. | Mar 2026 | -$13.66M | -4119958.4% | — | 4.7% |
| Mar 2026 | -$13.79M | -5.2% | — | 4.4% | |
| Mar 2026 | -$30.99M | -172.1% | — | 12.8% | |
| Peer median (excluding DMAA) | -$12.19M | -172.1% | — | 3.9% | |
Competitors are the stored peer set for DMAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 1.35K | 6.14K |
| Short-term Investments | 0 | 0 |
| Net Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Other Current Assets | 0 | 6.05K |
| Total Current Assets | 4.99K | 12.19K |
| Property, Plant & Equipment (Net) | 0 | 0 |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Long-term Investments | 0 | 0 |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 546 | 239.91M |
| Total Non-current Assets | 546 | 239.91M |
| Total Assets | 551 | 239.92M |
| Account Payables | 0 | 222.18K |
| Short-term Debt | 662 | 0 |
| Tax Payables | 0 | 0 |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | 56 | 0 |
| Total Current Liabilities | 796 | 376.17K |
| Long-term Debt | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 |
| Other Non-current Liabilities | 0 | 6.9M |
| Total Non-current Liabilities | 0 | 6.9M |
| Total Liabilities | 796 | 7.28M |
| Common Stock | 986 | 239.91M |
| Retained Earnings | (279) | (7.27M) |
| Accumulated OCI | 0 | 0 |
| Other Stockholders Equity | (985) | 0 |
| Minority Interest | 0 | 0 |
| Total Equity | (244) | 232.64M |
| Total Debt | 662 | 0 |
| Net Debt | 661 | (6.14K) |
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAA
Intrinsic Alpha fair value
Locked
Current Price
$10.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.